Evaluators
The evaluators are experts in technology assessment, financing and commercialization in the life science area, and are involved in the evaluation of the business ideas in phase 1 and the pre-selection of the 10 best business plans in phase 2.
All evaluators have signed a strict confidentiality agreement.
Mag. Dr. rer. nat. Daniel Alge
Patent attorney, Sonn & Partner, Vienna, Austria
Wolfram Anderle
Deputy Head Technology & Innovation, Austria Wirtschaftsservice, Vienna, Austria
Dr. Florian Becke
CAST, Innsbruck, Austria
Frank Butschbacher, CIR
Investor Relations & Communications, Mödling, Austria
Markus Costabiei, MBA
CEO, tech2b, Linz, Austria
DI Mag. Peter Feuereisel
Patent and Licensing Manager, Austria Wirtschaftsservice, Vienna, Austria
Dr. rer. nat. Irene Fialka
Consultant, INiTS, Vienna, Austria
Dr. Michaela Fritz
Program Coordinator Life Science Austria (LISA), Austria Wirtschaftsservice, Vienna, Austria
DI Dr. Gottfried Himmler
Founder, f-star, Vienna, Austria
DI Elvira Kainersdorfer
Project Manager, Austria Wirtschaftsservice, Vienna, Austria
Dr. Walter Koppensteiner, MBA
Market and Research Analyst, Austria Wirtschaftsservice, Vienna, Austria
DI Jürgen Kosch
CEO MIG Fonds, Munich, Germany
Dipl. Kaufm. Michael Krebs, Executive MBA
CEO, IMBA, Vienna, Austria
DI Otmar Kühner
External Consultant, SciencePark Graz, Austria
Zsombor Lacza, MD, PhD
CEO, Semmelweis Innovations Ltd., Budapest, Hungary
Dr. Manfred Lampl
Patent and Licensing Manager, Austria Wirtschaftsservice, Vienna, Austria
Ute Lassnig, Lizenziat Wirtschaftsinformatik
Partnerin, Mummert & Company Corporate Finance, Munich, Germany
Dr. Christian Laurer,
Senior Investment Manager, Tecnet Capital, St. Pölten, Austria
Alexander Matis, MSc, MBA
CEO at Nano S Biotechnologie and Innovative Diagnostics, Vienna; Austria Business Development Manager at BIRD-C, Vienna, Austria
Dr. Birgit Mayer
Forschungsförderungsgesellschaft, Vienna, Austria
DI Roland Moser
Project Manager, accent Gründerservice GmbH, Krems, Austria
Mr. Kazimierz Murzyn
Managing Director, LifeScience Cluster Krakow, Poland
Dr. Gerda Redl
Owner, Redl Life Science Patent Attorneys, Vienna, Austria
Dr. Arnold Reikerstorfer, MBA
Investment Manager, Austria Wirtschaftsservice, Vienna, Austria
Stefan Reisinger,
Nabriva Therapeutics AG, Vienna, Austria
Dr. Nina Sallacz,
Investment Manager, Austria Wirtschaftsservice, Vienna, Austria
Johannes Sarx, MBA
Investment Manager, Austria Wirtschaftsservice, Vienna, Austria
Dr. Angela Siegling
Patent and Licensing Manager, Austria Wirtschaftsservice, Vienna, Austria
Dr. Martin Spatz, MBA
Portfoliomanagement, Ratiopharm, Vienna, Austria
Mag. Gabriele Steinkogler-Scherzer
Innovation manager, BCCS, Salzburg, Austria
Mag. Tina Trofer
CEO, Geradeheraus Beratung, Vienna, Austria
Prof. RNDr. Jan Turna, CSc.
Chair of Department of Molecular Biology, Comenius University, Bratislava, Slovakia
Kristof Van Tomme, M.Sc. Bioengineering
CEO, Pronovix, Sleidinge, Belgium
Dr. Uwe Von Ahsen
Consultant, INiTS, Vienna, Austria
Ing. Monika Vrbková
External Affairs Manager/Consultant, South Moravian Innovation Center (JIC), Brno, Czech Republic
Mag. Bernhard Weber
Consultant, SciencePark Graz, Austria
Dr. Ludwig Weiss
CEO, Scixess, Kissing, Germany
